Vaccinex, Inc.
VCNX- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001205922
No open-market purchases or sales by Vaccinex, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Vaccinex, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 12 | 11 | −1 |
| Shares | 322.6K | 322.1K | −465 (−0.1%) |
| Value | $2.39M | $1.81M | −$582.7K (−24.4%) |
New holders (1)
Institutions that held Vaccinex, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bank of America Corp | 8 | $52 | 0.00% |
Sold out (2)
Institutions that held Vaccinex, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Tacita Capital Inc | 228 | $1.69K |
| UBS Group AG | 101 | $748 |